Pfizer (PFE) Tops Q2 EPS by 10c; Narrows FY Revenue Guidancce
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.72 -1.44%
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: -12.8%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q2 EPS of $0.67, $0.10 better than the analyst estimate of $0.57. Revenue for the quarter came in at $12.7 billion versus the consensus estimate of $12.08 billion.
GUIDANCE:
Pfizer sees FY2023 EPS of $3.25-$3.45, versus the consensus of $3.01. Pfizer narrows FY2023 revenue to $67-70 billion, versus $67-$71 billion prior and the consensus of $61 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Pfizer executive says China now leads Europe in drug innovation
- MSCI acquires First Street for $120M to expand climate risk data
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
